Therefore, we set out to test whether the effect of ABT 317 on common γ chain cytokine signaling could explain the difference between effects of IFN-γ/IFNγR deficiency and JAK1 inhibition on diabetes in NOD mice. Here, JAK1 is linked to diabetes mellitus.